Twitxy
Saved
@CouncilonHTN's profile picture
View on X

Council on Hypertension

@CouncilonHTN

Account of the Council on Hypertension. Doesn’t represent official views of @AHAScience. Tweets by @somijemmacho and @CFWenceslau
Joined July 2021
969 Following 1.9K Followers 1.5K Posts

Latest posts 5

Council on Hypertension @CouncilonHTN
Interesting findings from OPTIMAL-DIABETES trial demonstrating intensive BP-lowering (SBP <120 vs. <140) in Brazilian T2DM cohort + high CV risk did not significantly reduce the occurrence of major cardiovascular events! @AHAScience #ScientificSessions26
Henry Han Verified account @HanCardiomd 8h
Intensive BP Lowering in Patients with Type 2 DM : #OPTIMAL-DIABETES Trial

👥📍 9,476 patients | Mean age 64.7 years | 62% women

📍 Achieved SBP: 121.8 vs 135.4 mm Hg (intensive vs standard), Median follow-up: 4.0 years

📍 Primary outcome: 6.0% vs 6.7% — HR 0.90 (95% CI 0.77–1.06), P=0.20 → no significant benefit

⚠️📍 Serious AEs: 14.9% vs 14.6% — similar between groups

nejm.org/doi/full/10.10…

#ScientificSessions26 #AHA26 @AHAScience @NEJM
View quoted post on X
Council on Hypertension @CouncilonHTN
Congratulations to @jordy_bc on REDUCE trial demonstrating +spironolactone after stroke were more likely to reach the recommended BP goal <130/80 mmHg at three months than those receiving usual post-stroke care! @AHAScience #ScientificSessions26
Dr Anastasia Mihailidou FAHA FCSANZ FESC Verified account @AnastasiaSMihai 10h
Congratulations @jordy_bc presentimg outcomes of REDUCE #LBS 🔥 @AHAScience at #ScientificSessions26 👏👏

📍pts with prior ICH or Ischemic #Stroke receiving SPIRONOLACTONE significantly reduced home #BloodPressure at 6 mth with minimal SE
View quoted post on X
Council on Hypertension @CouncilonHTN
Reporting the newest #hypertension discovery from @AHAScience #ScientificSessions26! In the era of novel BP-lowering modalities, hyperaldosteronism remission after extended aldosterone synthase inhibition with substantial BP and ARR reduction!
Henry Han Verified account @HanCardiomd 14h
#Hyperaldosteronism Remission after Extended #Aldosterone Synthase Inhibition

14-patient cohort: Improvements persisted up to 2 years after treatment cessation. BP ⬇️ by approximately 25 mm Hg, with 23% estimated clinical success.

📌 Aldosterone-to-renin ratio: 210.0 → 1.29 at 1–2 years (n=9)—a 99.2% reduction (95% CI, 98.2–99.6).

nejm.org/doi/full/10.10…

#ScientificSessions26 #AHA26 @AHAScience
View quoted post on X